Day One Biopharmaceutical (NASDAQ:DAWN) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-24. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Day One Biopharmaceutical will report an earnings per share (EPS) of $-0.16.
Investors in Day One Biopharmaceutical are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Past Earnings Performance
The company’s EPS beat by $0.09 in the last quarter, leading to a 25.21% increase in the share price …